142 related articles for article (PubMed ID: 37058941)
1. A new strategy for searching determinants in colorectal cancer progression through whole-part relationship combined with multi-omics.
Xing F; Zheng R; Liu B; Huang K; Wang D; Su R; Feng S
Talanta; 2023 Jul; 259():124543. PubMed ID: 37058941
[TBL] [Abstract][Full Text] [Related]
2. Development of a Correlative Strategy To Discover Colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics.
Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ
Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524
[TBL] [Abstract][Full Text] [Related]
3. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
[TBL] [Abstract][Full Text] [Related]
4. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of multi-omics data for the discovery of biomarkers and therapeutic targets for colorectal cancer.
Zafari N; Bathaei P; Velayati M; Khojasteh-Leylakoohi F; Khazaei M; Fiuji H; Nassiri M; Hassanian SM; Ferns GA; Nazari E; Avan A
Comput Biol Med; 2023 Mar; 155():106639. PubMed ID: 36805214
[TBL] [Abstract][Full Text] [Related]
6. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer.
Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
[TBL] [Abstract][Full Text] [Related]
7. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
[TBL] [Abstract][Full Text] [Related]
8. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
9. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method.
Gallardo-Gómez M; De Chiara L; Álvarez-Chaver P; Cubiella J
Expert Rev Anticancer Ther; 2021 Jul; 21(7):723-738. PubMed ID: 33507120
[No Abstract] [Full Text] [Related]
11. Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer.
Du M; Gu D; Xin J; Peters U; Song M; Cai G; Li S; Ben S; Meng Y; Chu H; Chen L; Wang Q; Zhu L; Fu Z; Zhang Z; Wang M
Cell Rep Med; 2023 Mar; 4(3):100974. PubMed ID: 36921601
[TBL] [Abstract][Full Text] [Related]
12. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
13. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
Das V; Kalita J; Pal M
Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients.
Zhang W; Lin L; Xia L; Cai W; Dai W; Zou C; Yin L; Tang D; Xu Y; Dai Y
J Transl Med; 2021 Jun; 19(1):273. PubMed ID: 34174878
[TBL] [Abstract][Full Text] [Related]
15. Omics technologies for improved diagnosis and treatment of colorectal cancer: Technical advancement and major perspectives.
Dalal N; Jalandra R; Sharma M; Prakash H; Makharia GK; Solanki PR; Singh R; Kumar A
Biomed Pharmacother; 2020 Nov; 131():110648. PubMed ID: 33152902
[TBL] [Abstract][Full Text] [Related]
16. Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis.
Shen CJ; Chang KY; Lin BW; Lin WT; Su CM; Tsai JP; Liao YH; Hung LY; Chang WC; Chen BK
Theranostics; 2020; 10(16):7083-7099. PubMed ID: 32641980
[No Abstract] [Full Text] [Related]
17. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
[No Abstract] [Full Text] [Related]
18. A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers.
Liu H; Ye D; Chen A; Tan D; Zhang W; Jiang W; Wang M; Zhang X
Clin Chem Lab Med; 2019 Jun; 57(7):1073-1083. PubMed ID: 30978169
[TBL] [Abstract][Full Text] [Related]
19. Predictive biomarkers of colorectal cancer.
Ding D; Han S; Zhang H; He Y; Li Y
Comput Biol Chem; 2019 Dec; 83():107106. PubMed ID: 31542707
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive molecular biomarkers for the detection of colorectal cancer.
Kim HJ; Yu MH; Kim H; Byun J; Lee C
BMB Rep; 2008 Oct; 41(10):685-92. PubMed ID: 18959813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]